| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005890358 |
| P356 | DOI | 10.2165/11591660-000000000-00000 |
| P932 | PMC publication ID | 3394932 |
| P698 | PubMed publication ID | 21692547 |
| P5875 | ResearchGate publication ID | 51237756 |
| P2093 | author name string | Manpreet Singh | |
| Kiki Chang | |||
| Michelle Goldsmith | |||
| P2860 | cites work | The Neurobiology of the Switch Process in Bipolar Disorder | Q22241114 |
| Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder | Q22242745 | ||
| Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder | Q22242775 | ||
| The Columbia Suicide Screen: validity and reliability of a screen for youth suicide and depression | Q28235684 | ||
| Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) | Q28254748 | ||
| A children's global assessment scale (CGAS) | Q28271291 | ||
| Rapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants | Q28326442 | ||
| Availability: A heuristic for judging frequency and probability | Q29031561 | ||
| Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use | Q29391926 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder | Q33714517 | ||
| Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder | Q33929807 | ||
| Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. | Q33943502 | ||
| Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset | Q33945162 | ||
| Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment | Q33960349 | ||
| The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. | Q33969206 | ||
| Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors | Q34019994 | ||
| Pediatric mania: a developmental subtype of bipolar disorder? | Q34052800 | ||
| Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms | Q44554860 | ||
| Age effects on antidepressant-induced manic conversion | Q45003904 | ||
| Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. | Q45206307 | ||
| A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene | Q46301946 | ||
| Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder | Q46874086 | ||
| Antidepressant exposure in bipolar children | Q47204446 | ||
| Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features | Q47736888 | ||
| Pediatric bipolar disorder: phenomenology and course of illness | Q48588977 | ||
| Psychiatric phenomenology of child and adolescent bipolar offspring | Q48724679 | ||
| Unipolar depression in adolescents: clinical outcome in adulthood | Q48820908 | ||
| A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. | Q50924850 | ||
| Childhood antecedent disorders to bipolar disorder in adults: a controlled study. | Q51930938 | ||
| The rewards of reducing risk. | Q51938613 | ||
| Obsessive-compulsive bipolar comorbidity: focus on children and adolescents. | Q51942552 | ||
| Drug-induced disinhibition in psychiatrically hospitalized children. | Q51947616 | ||
| Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. | Q53950524 | ||
| Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. | Q53969282 | ||
| Manic symptoms in psychiatrically hospitalized children--what do they mean? | Q54057010 | ||
| Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood: a community-based longitudinal investigation. | Q54314611 | ||
| Medication-induced mania: ethical issues and the need for more research | Q58665486 | ||
| Methylphenidate challenge in a manic boy | Q69586803 | ||
| Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation | Q70392247 | ||
| The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study | Q71431506 | ||
| Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children | Q72000594 | ||
| Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants | Q72078495 | ||
| Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study | Q73125627 | ||
| Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young | Q73125631 | ||
| Regression to the mean | Q73447258 | ||
| The bottom line | Q73723356 | ||
| Controlled study of switching from attention-deficit/hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6-year prospective follow-up: rate, risk, and predictors | Q79299919 | ||
| Earlier onset of bipolar disorder in children by antidepressants or stimulants? An hypothesis | Q79364006 | ||
| Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype | Q80042732 | ||
| Current treatments of attention-deficit/hyperactivity disorder | Q80682784 | ||
| An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression | Q82844580 | ||
| Antidepressant-induced mania: an overview of current controversies | Q34278845 | ||
| Rationality in medical decision making: a review of the literature on doctors' decision-making biases | Q34328225 | ||
| Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorder | Q34422709 | ||
| Psychotropic practice patterns for youth: a 10-year perspective | Q35040724 | ||
| Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder | Q35103226 | ||
| A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors | Q35187141 | ||
| Challenges in the diagnosis and treatment of pediatric bipolar depression. | Q35237072 | ||
| Lithium treatment effects on Myo-inositol in adolescents with bipolar depression | Q35568324 | ||
| Studies of offspring of parents with bipolar disorder | Q35576965 | ||
| Treatment for Adolescents with Depression Study (TADS): safety results | Q35773690 | ||
| Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review | Q35909656 | ||
| Treatment guidelines for children and adolescents with bipolar disorder | Q36052032 | ||
| Review of the efficacy and safety of antidepressants in youth depression | Q36171352 | ||
| Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression | Q36286401 | ||
| Prevalence and correlates of bipolar I disorder among adults with primary youth-onset anxiety disorders | Q36392794 | ||
| Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents | Q36428445 | ||
| Psychopharmacologic treatment of pediatric major depressive disorder | Q36560433 | ||
| Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children | Q36677656 | ||
| Prevention of pediatric bipolar disorder: integration of neurobiological and psychosocial processes | Q36755271 | ||
| Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder | Q36827079 | ||
| Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial | Q37029242 | ||
| Clinical review of mania, hostility and suicide-related events in children and adolescents treated with antidepressants. | Q37577450 | ||
| Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria | Q37692726 | ||
| The pharmacogenetics of antidepressant‐induced mania: a systematic review and meta‐analysis | Q37805730 | ||
| Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. | Q38378026 | ||
| Conditioning and sensitisation in the longitudinal course of affective illness | Q39747714 | ||
| A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder | Q39961276 | ||
| A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity | Q40016044 | ||
| Developmental Pathways to Bipolarity: Are Juvenile-Onset Depressions Pre-Bipolar? | Q40442922 | ||
| Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study | Q40771273 | ||
| Antidepressant-induced mania and cycle acceleration: a controversy revisited | Q40977115 | ||
| Presentation and course of major depressive disorder during childhood and later years of the life span | Q41017525 | ||
| Methylphenidate-induced mania in a prepubertal child | Q42222631 | ||
| Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorder | Q43251751 | ||
| Antidepressant-induced mania in bipolar patients: identification of risk factors. | Q43622365 | ||
| Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study | Q43789283 | ||
| Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial | Q44168453 | ||
| A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder | Q44326251 | ||
| Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial | Q44525396 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 225-243 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | Pediatric Drugs | Q15767256 |
| P1476 | title | Antidepressants and psychostimulants in pediatric populations: is there an association with mania? | |
| P478 | volume | 13 |
| Q47741604 | A Long-Term, Open-Label, Safety Study of Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD. |
| Q38653732 | A Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder |
| Q47990576 | Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study. |
| Q47642434 | Antidepressant-induced activation in children and adolescents: Risk, recognition and management |
| Q90069794 | Antidepressants for Pediatric Patients |
| Q22252565 | Bipolar Depression in Pediatric Populations |
| Q38097548 | Bipolar depression in children and adolescents |
| Q38530480 | Bipolar disorder and ADHD: comorbidity and diagnostic distinctions |
| Q52656684 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. |
| Q36766510 | Characteristics of the child behavior checklist in adolescents with depression associated with bipolar disorder |
| Q38260191 | Distinguishing bipolar disorder from other psychiatric disorders in children |
| Q38591224 | Early interventions for youths at high risk for bipolar disorder: a developmental approach |
| Q37403251 | Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders |
| Q38793543 | Ethical considerations in preventive interventions for bipolar disorder |
| Q34675928 | Intervention in the context of development: pathways toward new treatments |
| Q36303876 | Interventions for youth at high risk for bipolar disorder and schizophrenia |
| Q38862711 | Longitudinal course and characteristics of cyclothymic disorder in youth |
| Q38241131 | Managing the risks of ADHD treatments |
| Q36925768 | Neural Function Before and After Mindfulness-Based Cognitive Therapy in Anxious Adolescents at Risk for Developing Bipolar Disorder |
| Q34282760 | Neuroprogression in bipolar disorder |
| Q89126453 | Parsing cyclothymic disorder and other specified bipolar spectrum disorders in youth |
| Q28282770 | Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents |
| Q46405750 | Receiver Operating Characteristic Curve Analysis of Screening Tools for Bipolar Disorder Comorbid With ADHD in Schoolchildren |
| Q88193781 | The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis |
| Q47114336 | The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research. |
| Q26850357 | The neural effects of psychotropic medications in children and adolescents |
| Q52674786 | Treatment of psychiatric symptoms among offspring of parents with bipolar disorder. |
| Q30888931 | Using neuroimaging to evaluate and guide pharmacological and psychotherapeutic treatments for mood disorders in children |
Search more.